Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Clinical trial NCT03395197 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03395197
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2022-10-03
- Enrollment
- 1054
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.